Next Article in Journal
Effect of Itraconazole on the Pharmacokinetics of Diclofenac in Beagle Dogs
Previous Article in Journal
Absorption, Distribution and Excretion of 14C-Probimane in Mice Bearing Lewis Lung Carcinoma
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessArticle
Sci. Pharm. 2010, 78(3), 451-464; (registering DOI)

Behavioral and Developmental Changes in Rats with Prenatal Exposure of Mirtazapine

Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi 835215, India
Author to whom correspondence should be addressed.
Received: 4 April 2010 / Accepted: 30 June 2010 / Published: 30 June 2010
PDF [584 KB, uploaded 29 September 2016]


Mirtazapine is an often used antidepressant drug; however insufficient information is available regarding its safety during pregnancy. Therefore, this work was initiated to study the effect of prenatal exposure of mirtazapine on postnatal developments of rats. The study was conducted on pregnant rats to observe the safety profile of mirtazapine in comparison to control. The percentage weight gain, gestation period and litter size of the rats treated with double therapeutic dose (DTD) was significantly lower than the rats treated with therapeutic dose (TD) and rats of control group. However the litter size of the TD treated rats was also found smaller than the control. The offspring were examined through battery of test in order to evaluate their developmental neurotoxicity. The test includes the assessment of postnatal growth, reflex ontogeny, neuromotor abilities, activity level, emotional reactivity and learning ability. The DTD exposure negatively affected on overall growth of pups in comparison to TD exposed pups and control group. Further, the amine concentration in brain was also found significantly lower in DTD exposed pups. Therefore, this study reveals that the treatment of pregnant rats with TD and DTD decreases their litter size. In addition the prenatal exposure of DTD of mirtazapine negatively affects on neurodevelopment of rats.
Keywords: Prenatal exposure; Behavioral development; Mirtazapine Prenatal exposure; Behavioral development; Mirtazapine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

SAHOO, J.; PATTNAIK, A.K.; MISHRA, N. Behavioral and Developmental Changes in Rats with Prenatal Exposure of Mirtazapine. Sci. Pharm. 2010, 78, 451-464.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top